Home
Shattuck Labs

Shattuck Labs Market Share Analysis for August 2026

Learn about Shattuck Labs - an experienced team of physicians, scientists, and protein engineers developing transformative medicines targeting TNF receptors.

Health > Biotechnology and Pharmaceuticals

Domainshattucklabs.com

Year Founded2016

Employees51 - 200

Annual Revenue$1M - $2M

Shattuck Labs

Shattuck Labs (including company regionals)

shattucklabs.com

See more website traffic and engagement information

Shattuck Labs Revenue up to August 2026 is 1M - 2M

revenue generated by Shattuck Labs top domains

Shattuck Labs top domains revenue over 3 years

Revenue for Shattuck Labs top domains

shattucklabs.com1M - 2M

See more with Sales Intelligence

Total visits to Shattuck Labs's top domains

Understand Shattuck Labs market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

shattucklabs.com3.7K

See more with Sales Intelligence

Avg. visit duration in Shattuck Labs's top domains

Analyze Shattuck Labs engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

shattucklabs.com00:00:39

See more with Sales Intelligence

Avg. pageviews on Shattuck Labs's top domains

See how Shattuck Labs keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

shattucklabs.com2.17

See more with Sales Intelligence

Shattuck Labs top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Shattuck Labs

These are the website technologies, by industry, used by Shattuck Labs top domains

Widget (3)

Twemoji

Conversion & Analytics (2)

Google Analytics

Email Services (2)

Microsoft Exchange Online

Marketing (2)

Google Marketing Platform

More Technologies

10

See all

News & Signals from Shattuck Labs

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsShattuck Labs, Inc. will develop SL-846 on Jul 1st '27.Shattuck is also developing SL-846, a potential first-in-class, half-life extended DR3 x IL-23 receptor bispecific antibody.

NewsShattuck Labs, Inc. attended event Piper Sandler Virtual Novel Targets in Immunology Symposium on Feb 12th '26.AUSTIN, TX and DURHAM, NC, Feb. 06, 2026 (GLOBE NEWSWIRE) - Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-mediated diseases, today announced that company management will participate in a fireside chat at the Piper Sandler Virtual Novel Targets in Immunology Symposium, taking place February 12-13, 2026.

NewsShattuck Labs, Inc. attends event UEGW Conference 2025.Shattuck Labs, Inc. to participate in Panel Discussion at UEGW Conference 2025.